Slide 1: Stock exchange intimation cover letter
Date: November 07, 2025 Ref. No.: KDL/SE/074/2024-25 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 4
Slide 2: Q2 FY2026 Result Presentation
Q2 FY2026 Result Presentation One of INDIA’S LARGEST Integrated Diagnostic Service Provider
Slide 3: Disclaimer
Disclaimer This presentation contains statements that are “forward-looking statements”, including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements pertaining to Krsnaa Diagnostics’ future business developments and economic performance.
Slide 4: Krsnaa Diagnostics Limited
DIAGNOSTICS Krsnaa Diagnostics Limited
Slide 5: Krsnaa Diagnostics At a Glance
186 75 CT/ MRI Centres 3,500+ Million+ Patient Collectionn Centres Patients Served Since Inception Krsnaa Diagnostics At a Glance 120 18 Pathology Labs States/UT Presence in India One of India’s largest NABH accredited Krsnaa Diagnostics is one of the fastest tele-radiology reporting hub with growin
Slide 6: Retail Dynamics
Retail Dynamics Retail Revenue (mn) Retail Revenue Contribution to Group Revenue 8% 174 “Q-o-Q Retail 16 1% Business Q2 FY25 Q2 FY26 Q2 FY25 Q2 FY26 Revenue No. of Touch Points 90% Segment Retail Revenue Mix B2B B2C Increased By 2,878 76% 60%” 24% 608 10% Q2 FY25 Q2 FY26 Q2 FY25 Q2 FY26 © Krsnaa Dia
Slide 7: Q2 FY26 Financial Performance
Q2 FY26 Financial Performance Achieved All-Time High Quarterly PAT of INR 239 Mn, Rising 22% Y-o-Y on Strengthening Margins and Operating Leverage Particulars Q2 FY26 Q2 FY25 Growth Particulars Q2 FY26 Q2 FY25 Growth Revenue 2,060 1,863 11% EPS 7.3 5.9 24% EBIDTA 602 509 18% No. of Patient Served 5.
Slide 8: Q2 FY26 – Centre Growth
Q2 FY26 – Centre Growth CT Centre MRI Centre Tele- Radiology Centre Upon completion of our existing 146 40 order book, we will have 139 39 1,501 200+ CT/MRI centres, Radiology 1,434 cementing our position as one of Asia’s Largest Radiology Players. Q2 FY25 Q2 FY26 Q2 FY25 Q2 FY26 Q2 FY25 Q2 FY26 Ref
Slide 9: Competitive Advantages
Competitive Advantages
Slide 10: Driving Excellence Through Quality
Driving Excellence Through Quality India’s 1st ACR Accredited Company India’s 1st CAP Accredited Lab India’s 1st NABH Accredited at Government Facility Tele-Radiology Hub Service Excellence Pioneers of Indian Diagnostic Industry © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 9
Slide 11: Driving Excellence Through Quality
Driving Excellence Through Quality 57 36 National Accreditation for Board of National Accreditation Board for testing's & Calibration Laboratories Hospitals & Healthcare Providers We are committed to delivering superior quality as our benchmark and proudly served ~5.4 mn patients in Q2 FY26, driven
Slide 12: Our Strengths
Our Strengths The only listed company in PPP (Public Private 18 states and union Partnership) space with bid territories with penetration till ~75 Mn+ patients served since win ratio of 75%+ tier-II and tier-III towns inception Integrated diagnostic services Quality diagnostic services at Operationa
Slide 13: Our Pricing - Everyone Can Afford
Our Pricing - “Everyone Can Afford” % lower from Segment Test Competition 1 Competition 2 Competition 3 Krsnaa competitors Radiology CT Brain 4,500 4,500 3,500 880 (75)% Radiology MRI Brain 8,000 8,250 7,000 1,340 (81)% Pathology CBC 250 250 200 37 (82)% Pathology Blood Sugar 85 80 70 20 (71)% Patho
Slide 14: Presence - PAN India
Presence - PAN India Well Diversified Regional Revenue Mix 15% 35% Q2 FY26 44% 13% West South North East India map for representation only, not to scale © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 13
Slide 15: New Centres
DIAGNOSTICS New Centres
Slide 16: State-Of-Art Infrastructure Enabling Reliable Diagnostics
State-Of-Art Infrastructure Enabling Reliable Diagnostics Soon to be operationalized AI-Enabled MRI Centres Amravati, Maharashtra Buldhana, Maharashtra Actual centre images © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 15
Slide 17: State-Of-Art Infrastructure Enabling Reliable Diagnostics
State-Of-Art Infrastructure Enabling Reliable Diagnostics Soon to be Operationalized Low Radiation CT Scan Centres Ranchi, Jharkhand Tuljapur, Maharashtra Actual centre images © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 16
Slide 18: Financial Performance
DIAGNOSTICS Financial Performance
Slide 19: Consolidated Financial Performance
Consolidated Financial Performance Particulars Q2 FY 26 Q2 FY 25 Q1 FY 26 H1 FY 26 H1 FY 25 Amount % Amount % Amount % Amount % Amount % Revenue from operations 2,060 1,863 1,930 3,990 3,566 Expenses Cost of Material Consumed 481 23% 449 24% 474 25% 955 24% 878 25% Employee benefits expense 348 17%
Slide 20: Consolidated Financial Performance
Consolidated Financial Performance (INR In Mn) Assets Sep 30, 2025 Mar 31, 2025 Liabilities Sep 30, 2025 Mar 31, 2025 Non-current assets Equity Equity share capital 162.19 161.45 Property, plant and equipment 6,800.17 6,674.34 Other equity 9,067.36 8,666.25 Capital work-in-progress 302.05 29.63 Tota
Slide 21: Krsnaa Diagnostics
For further information please contact Krsnaa Diagnostics Vivek Jain, Head- Investor Relations head.investor@krsnaa.in Contact: +91 74107 00645 https://krsnaadiagnostics.com